POTASSIUM IODIDE Drug Patent Profile
✉ Email this page to a colleague
When do Potassium Iodide patents expire, and when can generic versions of Potassium Iodide launch?
Potassium Iodide is a drug marketed by Mission Pharmacal and Roxane and is included in two NDAs.
The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Iodide
A generic version of POTASSIUM IODIDE was approved as potassium iodide by MISSION PHARMACAL on March 24th, 2016.
Summary for POTASSIUM IODIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 212 |
Clinical Trials: | 27 |
Patent Applications: | 2,772 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for POTASSIUM IODIDE |
DailyMed Link: | POTASSIUM IODIDE at DailyMed |
Recent Clinical Trials for POTASSIUM IODIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prof. Gerasimos Sykiotis | N/A |
National Cancer Institute (NCI) | Phase 2 |
Pediatric Brain Tumor Consortium | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM IODIDE
US Patents and Regulatory Information for POTASSIUM IODIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mission Pharmacal | POTASSIUM IODIDE | potassium iodide | SOLUTION;ORAL | 206211-001 | Mar 24, 2016 | OTC | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roxane | POTASSIUM IODIDE | potassium iodide | SOLUTION;ORAL | 018551-001 | Feb 19, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |